Clinical Trials
2 trialsNCT05243524 2023-09-13
AVALON
ImmunoVaccine Technologies, Inc. (IMV Inc.)
Phase 2 Terminated
NCT03081702 2021-04-02
A Study of the Safety, Tolerability and Effectiveness of Hydroxychloroquine and Itraconazole in Platinum-resistant Epithelial Ovarian Cancer
University Health Network, Toronto
Phase 1/2 Completed